Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity

Related Experiment Video

Updated: Oct 16, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

A Hlobilkova1, P Guldberg, M Thullberg

  • 1Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, Copenhagen O, DK-2100, Denmark.

Experimental Cell Research
|April 25, 2000
PubMed

Insights

The tumor suppressor PTEN

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • PTEN is a crucial tumor suppressor gene implicated in various cancers.
  • Its known function involves lipid phosphatase activity, particularly in glioma suppression.
  • The role of PTEN's protein phosphatase activity in other cancers remains unclear.

Purpose of the Study:

  • To investigate the role of PTEN's protein phosphatase activity in human breast cancer.
  • To determine if exogenous PTEN can inhibit breast cancer cell proliferation.
  • To differentiate the effects of lipid versus protein phosphatase activity of PTEN.

Main Methods:

  • Introduction of exogenous wild-type and mutant PTEN into human breast cancer cell lines.
  • Cell cycle analysis (G1 arrest) was performed.
  • Specific PTEN mutants with deficiencies in lipid or protein phosphatase activity were utilized.

Main Results:

  • Wild-type PTEN induced G1 arrest in some breast cancer cell lines, independent of endogenous PTEN.
  • A PTEN mutant (G129E) deficient in lipid phosphatase activity still inhibited cell cycle progression.
  • PTEN mutants lacking both phosphatase activities (G129R, H123Y) failed to arrest cells.

Conclusions:

  • PTEN's protein phosphatase activity contributes to tumor suppression in specific cancer types.
  • Understanding PTEN's downstream targets is vital for developing novel cancer therapies.
  • These findings highlight the complex roles of PTEN in cancer beyond its lipid phosphatase function.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...